【港股异动 | 药捷安康-B(02617.HK)涨超8%创新高 替恩戈替尼联用开坦尼/依达方的II期临床试验完成首例患者给药】智通财经APP获悉，药捷安康-B(02617.HK)盘中涨超8%，高见64.8港元创上市新高，较招股价13.15港元涨近4倍。截至发稿，涨5.26%，报63港元，成交额1180.9万港元。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.